Hypertension (high blood pressure) Board decisions

The Board remands the claims for service connection for various conditions, including diabetes mellitus, type II, and peripheral neuropathy in both lower extremities, among others.

The Board remands the claims for further development, including obtaining a complete medical history and an adequate examination to determine the nature and etiology of the Veteran's conditions.

The appeal for asbestosis was granted, while the claims for a compensable rating for hypertension and service connection for an upper respiratory condition were remanded.

The appeal was dismissed due to the Veteran's death during the pendency of the appeal.

The appeal was partially granted by reopening the claim for service connection for Ischemic Heart Disease (IHD) but denied for both conditions.

The Board remands the claims for increased disability ratings and special monthly compensation based on housebound status due to incomplete development of the record.

The Board remands the claim for an addendum opinion regarding the nature and etiology of the Veteran's hypertension.

The Board remands the claims for service connection for obstructive sleep apnea and hypertension as secondary to a lumbar spine disorder, requiring new VA medical opinions addressing the aggravation aspect of secondary service connection and toxic exposure under the PACT Act.

The Board denied service connection for anxiety disorder, high blood pressure (hypertension), atherosclerotic heart disease, type II diabetes mellitus, and diabetic neuropathy of the bilateral upper and lower extremities. The effective date for service connection for bilateral hearing loss was also denied.

The appeal with respect to entitlement to an initial rating in excess of 10 percent for hypertension is dismissed due to the fact that the June 2024 rating decision merely implemented the Board's June 2024 decision as to the initial rating to be assigned for hypertension.

The Board remands the claims for service connection for bladder cancer, hypertension, anxiety, depression, and erectile dysfunction due to a need for further evidence regarding herbicide exposure in Korea.

The Board remands the claims for the restoration of disability ratings for a right hand scar and hypertension, as the AOJ did not address the correct issues in its decision.

The Board granted a non-compensable rating for hypertension prior to December 17, 2024, and a compensable rating of 10 percent from that date. Service connection was also granted for heart disability manifested by hypertensive heart disease as secondary to hypertension, but denied for residuals of a stroke and diabetes.

The Board granted a total disability rating based on individual unemployability (TDIU) and awarded an earlier effective date for special monthly compensation based on loss of use of a creative organ, but denied other claims.

The Board denied the Veteran's claims for service connection for hypertension and congestive heart failure, finding no credible evidence of herbicide exposure or a link to service.

The Board denied service connection for decreased memory due to the absence of a current disability, while remanding claims for non-alcoholic fatty liver with cirrhosis, hypothyroidism, hypertension, and obstructive sleep apnea (OSA) for further development.

The Board denied the veteran's claims for an earlier effective date and a compensable rating for hypertension, as the evidence did not support these requests.

The Board denied a compensable rating for hypertension and an earlier effective date prior to June 10, 2015 for the grant of service connection for coronary artery disease.

The Board denied an initial compensable rating for the Veteran's service-connected hypertension as the evidence did not show diastolic pressure predominantly 100 or more, systolic pressure predominantly 160 or more, or a history of such readings requiring continuous medication.

The Board granted service connection for kidney disease and hypertension as secondary to the Veteran's now service-connected kidney disease.